12:00 AM
Feb 20, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Sancuso granisetron patch regulatory update

EMA's CHMP issued a positive opinion recommending approval of an MAA for Sancuso granisetron transdermal patch from Kyowa's ProStrakan Ltd. subsidiary to prevent nausea and vomiting...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >